Prep & Injection Guide
A structured reference for storage, measurement, aseptic preparation, route awareness, and responsible disposal in qualified research settings.
Safety first
This guide does not authorize self-administration. Injectable preparation and administration require trained personnel, an approved protocol, sterile supplies, verified compound identity and concentration, and compliance with applicable institutional and legal requirements.
- Confirm the vial label, lot, concentration, solvent, route, storage requirement, beyond-use date, and protocol before beginning.
- Use the product-specific manufacturer instructions, certificate of analysis, safety data, and institutional SOP whenever they differ from a general guide.
- Never improvise a solvent, concentration, route, needle, storage condition, or reuse schedule.
- Do not proceed with damaged, unlabeled, expired, discolored, cloudy, leaking, or visibly contaminated material.
Storage & stability
Peptide stability depends on the exact molecule and formulation. Temperature changes, light, humidity, repeated freeze–thaw cycles, agitation, and mechanical shock can promote degradation or aggregation.
Keep sealed, dry, protected from light, and within the supplier’s documented temperature range. Do not assume every peptide tolerates the same refrigerator or freezer conditions.
Label the preparation date, concentration, solvent, storage condition, and discard date. Minimize temperature cycling and follow formulation-specific stability data.
Storage checklist
- Use an opaque or light-protective secondary container.
- Keep vials upright and away from refrigerator doors, vibration, moisture, and food contamination.
- Freeze only when supported by product-specific data; aliquot before freezing when an approved SOP requires it.
- Never refreeze a thawed preparation unless validated stability data explicitly permits it.
- Some lipotropic and non-peptide solutions must not be refrigerated; confirm the individual profile.
Supplies & work area
- Clean, disinfected work surface with adequate lighting.
- Hand hygiene supplies and appropriate personal protective equipment.
- New sterile, single-use syringes and needles appropriate to the approved task.
- 70% isopropyl alcohol pads, compatible sterile diluent, labels, and a puncture-resistant sharps container.
- Protocol, concentration calculation, and independent verification when required.
Needles and syringes are single-use. Never reuse, share, place an exposed needle on a surface, or recap by hand after use. Dispose of the complete device immediately in an approved sharps container.
Syringe measurement
“Units” on a U-100 insulin syringe describe volume, not peptide mass. The mass delivered depends entirely on vial amount and final liquid volume.
| U-100 marking | Liquid volume | Important note |
|---|---|---|
| 1 U | 0.01 mL | Mass must be calculated from the verified concentration. |
| 10 U | 0.10 mL | Confirm the syringe is actually U-100. |
| 50 U | 0.50 mL | Barrel capacity does not change the meaning of a U-100 unit. |
| 100 U | 1.00 mL | Do not transfer unit values between different concentrations. |
Before measuring
- Verify vial mass and final volume.
- Calculate concentration in mass per mL.
- Convert the protocol amount to mL, then to the correct syringe marking.
- Have another qualified person verify high-risk or unusually small measurements.
Use the Peptide Calculator only as a mathematical aid; it does not validate the protocol or product.
Aseptic reconstitution workflow
- Review the compound-specific instructions and confirm the exact compatible diluent and volume.
- Perform hand hygiene, disinfect the work area, assemble supplies, and inspect all packaging.
- Clean vial stoppers with separate alcohol pads and allow them to air-dry fully.
- Using a new sterile device, withdraw the verified diluent volume without touching critical sterile surfaces.
- Introduce diluent slowly against the vial wall when compatible with the formulation. Do not direct a forceful stream at fragile powder.
- Mix only as instructed. Gentle swirling may be appropriate; avoid shaking unless the manufacturer specifically requires it.
- Inspect for complete dissolution, unexpected particles, discoloration, cracks, leaks, or compromised seals.
- Label the final concentration, diluent, preparation time, storage condition, initials, and discard date.
Stop if the calculation, solvent, concentration, sterility, appearance, stability, or product identity is uncertain. Quarantine the material and obtain qualified review.
Administration-route reference
Route selection is protocol- and formulation-specific. This section distinguishes routes; it is not a patient injection tutorial.
| Route | Research context | Key controls |
|---|---|---|
| Subcutaneous | Delivery into subcutaneous tissue with generally slower absorption than intramuscular administration. | Approved site, appropriate sterile device, site rotation, tissue assessment, and protocol-specific volume limits. |
| Intramuscular | Delivery into muscle, often with faster absorption and different volume/device requirements. | Anatomical training, correct needle selection, avoidance of nerves and vessels, and professional competency. |
| Topical / oral / buccal | Non-injectable formulations with route-specific handling and absorption characteristics. | Use only a formulation manufactured or validated for that route; injectable preparations are not automatically interchangeable. |
Pre-administration verification
- Right compound, concentration, protocol amount, route, time, subject identifier, and documentation.
- Intact sterile device and clean site prepared under the governing SOP.
- No visible contamination or unresolved calculation discrepancy.
- Emergency and incident procedures are available to trained personnel.
Disposal, documentation & stop conditions
- Place used needles and syringes directly into a compliant sharps container; do not recap, bend, break, or detach by hand.
- Dispose of vials, solvents, wipes, and contaminated materials under local biomedical-waste and institutional rules.
- Document lot numbers, preparation details, calculated concentration, storage history, administration record, observations, and deviations.
- Stop and escalate after a needlestick, spill, suspected contamination, labeling error, dosing discrepancy, unexpected reaction, or cold-chain failure.
For qualified laboratory research only. Not for human or veterinary use, diagnosis, treatment, or unsupervised administration.